PROTECTIVE LIFE CORP
10-Q, 1997-11-12
LIFE INSURANCE
Previous: NATIONAL GAS & OIL CO, 10-Q, 1997-11-12
Next: PROTECTIVE LIFE CORP, 424B5, 1997-11-12




- -------------------------------------------------------------------------------


                                    FORM 10-Q
                      ------------------------------------


                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D. C. 20549


              [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                For the quarterly period ended SEPTEMBER 30, 1997

                                       OR

              [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                        For the transition period from to



                         Commission File Number 1-12332

                           PROTECTIVE LIFE CORPORATION
             (Exact name of registrant as specified in its charter)

              DELAWARE                                  95-2492236
(State or other jurisdiction of            (IRS Employer Identification Number)
 incorporation or organization)


                             2801 HIGHWAY 280 SOUTH
                            BIRMINGHAM, ALABAMA 35223
              (Address of principal executive offices and zip code)

                                 (205) 879-9230
              (Registrant's telephone number, including area code)

                      ------------------------------------


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes [X] No [ ]

Number of shares of Common Stock, $.50 par value, outstanding as of November 7, 
1997: 30,814,136 shares.



<PAGE>





                           PROTECTIVE LIFE CORPORATION



                                      INDEX



                                                                              
PART I.   FINANCIAL INFORMATION:
   Item 1.   Financial Statements:
        Report of Independent Accountants...................................
        Consolidated Condensed Statements of Income for the Three and Nine
          Months ended September 30, 1997 and 1996 (unaudited)..............
        Consolidated Condensed Balance Sheets as of September 30, 1997
          (unaudited) and December 31, 1996.................................
        Consolidated Condensed Statements of Cash Flows for the
          Nine Months ended September 30, 1997 and 1996 (unaudited).........
        Notes to Consolidated Condensed Financial Statements (unaudited)....
   Item 2.  Management's Discussion and Analysis of Financial Condition
              and Results of Operations.....................................

PART II.  OTHER INFORMATION:
   Item 6.  Exhibits and Reports on Form 8-K................................


Signature...................................................................



<PAGE>





                        REPORT OF INDEPENDENT ACCOUNTANTS



To the Directors and Stockholders
Protective Life Corporation
Birmingham, Alabama


We have  reviewed  the  accompanying  consolidated  condensed  balance  sheet of
Protective Life  Corporation and  subsidiaries as of September 30, 1997, and the
related  consolidated  condensed  statements of income for the  three-month  and
nine-month periods ended September 30, 1997 and 1996 and consolidated  condensed
statements of cash flows for the nine-month periods ended September 30, 1997 and
1996.  These  financial  statements  are  the  responsibility  of the  Company's
management.

We conducted our review in accordance with standards established by the American
Institute  of  Certified  Public  Accountants.  A review  of  interim  financial
information consists principally of applying analytical  procedures to financial
data and making  inquiries of persons  responsible  for financial and accounting
matters. It is substantially less in scope than an audit conducted in accordance
with  generally  accepted  auditing  standards,  the  objective  of which is the
expression of an opinion  regarding the financial  statements  taken as a whole.
Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material  modifications that should
be made to the consolidated condensed financial statements referred to above for
them to be in conformity with generally accepted accounting principles.

We have  previously  audited,  in accordance  with generally  accepted  auditing
standards,  the  consolidated  balance  sheet as of December 31,  1996,  and the
related consolidated statements of income,  stockholders' equity, and cash flows
for the year then ended (not presented herein); and in our report dated February
11, 1997,  we expressed an  unqualified  opinion which  contains an  explanatory
paragraph   regarding  the  changes  in  accounting  for  stock-based   employee
compensation plans in 1995 on those consolidated  financial  statements.  In our
opinion,  the information set forth in the accompanying  consolidated  condensed
balance sheet as of December 31, 1996, is fairly stated in all material respects
in relation to the consolidated balance sheet from which it has been derived.




COOPERS & LYBRAND L.L.P.

Birmingham, Alabama
October 23, 1997

                                        2

<PAGE>



                           PROTECTIVE LIFE CORPORATION
                   CONSOLIDATED CONDENSED STATEMENTS OF INCOME
                 (Dollars in thousands except per share amounts)
                                   (Unaudited)

<TABLE>
<CAPTION>

                                                                           THREE MONTHS ENDED              NINE MONTHS ENDED
                                                                               SEPTEMBER 30                    SEPTEMBER 30
                                                                    ------------------------------    ---------------------
 
                                                                             1997           1996            1997           1996
                                                                             ----           ----            ----           ----

<S>                                                                        <C>            <C>              <C>           <C> 
REVENUES
Premiums and policy fees (net of reinsurance ceded:
     three months: 1997 - $95,507; 1996 - $81,453
     nine months: 1997 - $221,292; 1996 - $247,988)                        $116,246       $118,696         $363,817      $366,533
Net investment income                                                       158,196        129,309          426,001       384,149
Realized investment gains                                                        61            861              786         5,882
Other income                                                                  8,222          5,079           21,890        15,509
                                                                         ----------     ----------        ---------     ---------
                                                                            282,725        253,945          812,494       772,073
                                                                          ---------      ---------         --------      --------


BENEFITS AND EXPENSES
Benefits and settlement expenses (net of reinsurance ceded:
     three months: 1997 - $51,059; 1996 - $64,420
    nine months: 1997 - $93,780; 1996 - $182,201)                           163,880        162,635          496,712       479,832
Amortization of deferred policy acquisition costs                            28,516         18,822           67,561        70,162
Other operating expenses (net of reinsurance ceded:
    three months: 1997 - $26,459; 1996 - $24,368
    nine months: 1997 - $63,086; 1996 - $67,183)                             41,475         40,932          116,618       120,860
                                                                           --------      ---------         --------      --------
                                                                            233,871        222,389          680,891       670,854
                                                                           --------       --------         --------      --------

INCOME BEFORE INCOME TAX AND MINORITY
  INTEREST                                                                   48,854         31,556          131,603       101,219

Income tax expense                                                           16,610         10,730           44,745        34,415
                                                                           --------      ---------        ---------       -------

INCOME BEFORE MINORITY INTEREST                                              32,244         20,826           86,858        66,804

Minority interest in net income
    of consolidated subsidiaries                                              1,810            804            4,111         2,413
                                                                          ---------     ----------        ---------     ---------

NET INCOME                                                                 $ 30,434       $ 20,022         $ 82,747      $ 64,391
                                                                         ==========       ========         ========      ========

NET INCOME PER SHARE                                                     $      .97     $      .64       $     2.65    $     2.15
                                                                         ==========     ==========       ==========    ==========

DIVIDENDS PAID PER SHARE                                                 $      .20     $      .18      $       .58   $       .52
                                                                         ==========     ==========      ===========   ===========

Average shares outstanding                                               31,252,722     31,147,723       31,219,799    29,995,190






</TABLE>

SEE NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

                                        3

<PAGE>

<TABLE>
<CAPTION>


                                           PROTECTIVE LIFE CORPORATION
                                      CONSOLIDATED CONDENSED BALANCE SHEETS
                                             (Dollars in thousands)
                                                                                  SEPTEMBER 30         DECEMBER 31
                                                                                     1997                 1996
                                                                              -------------------------------------
ASSETS                                                                            (Unaudited)
<S>                                                                               <C>                  <C>   
  Investments:
    Fixed maturities                                                              $ 6,157,588          $4,686,072
    Equity securities                                                                  18,620              35,250
    Mortgage loans on real estate                                                   1,261,809           1,503,080
    Investment real estate, net                                                        14,770              14,305
    Policy loans                                                                      194,190             166,704
    Other long-term investments                                                        66,630              32,506
    Short-term investments                                                            202,463             114,258
                                                                                 ------------         -----------
        Total investments                                                           7,916,070           6,552,175
    Cash                                                                                  310             121,051
    Accrued investment income                                                          92,058              70,544
    Accounts and premiums receivable, net                                              42,175              47,371
    Reinsurance receivables                                                           473,521             332,614
    Deferred policy acquisition costs                                                 630,330             488,384
    Property and equipment, net                                                        37,431              36,091
    Other assets                                                                       83,542              64,278
    Assets held in separate accounts                                                  880,083             550,697
                                                                                -------------         -----------
                                                                                  $10,155,520          $8,263,205
                                                                                  ===========          ==========

LIABILITIES
    Policy liabilities and accruals                                              $  3,584,204          $2,709,386
    Guaranteed investment contract deposits                                         2,784,252           2,474,728
    Annuity deposits                                                                1,481,726           1,331,067
    Other policyholders' funds                                                        170,051             142,221
    Other liabilities                                                                 222,857             170,442
    Accrued income taxes                                                               16,761              (4,521)
    Deferred income taxes                                                              36,058              37,869
    Debt                                                                              138,600             181,000
    Liabilities related to separate accounts                                          880,083             550,697
                                                                               --------------        ------------
                                                                                    9,314,592           7,592,889
                                                                                -------------         -----------

COMMITMENTS AND CONTINGENT LIABILITIES - NOTE B

GUARANTEED PREFERRED BENEFICIAL INTERESTS
    IN COMPANY'S SUBORDINATED DEBENTURES
    9% Cumulative Monthly Income Preferred Securities, Series A                        55,000              55,000
    8.25% Trust Originated Preferred Securities                                        75,000
                                                                               --------------        ------------
                                                                                      130,000              55,000
                                                                                -------------        ------------

STOCKHOLDERS' EQUITY
    Preferred Stock, $1 par value
        Shares authorized: 3,600,000; Issued: none
    Junior Participating Cumulative Preferred Stock, $1 par value
        Shares authorized: 400,000; Issued:  none
    Common Stock, $0.50 par value
        Shares authorized: 80,000,000
        Issued: 1997 and 1996 - 33,336,462                                             16,668              16,668
    Additional paid-in capital                                                        167,668             166,713
    Net unrealized gains on investments
        (net of income tax: 1997 - $22,139; 1996 - $3,601)                             37,754               6,688
    Retained earnings                                                                 506,918             442,046
    Treasury stock (1997 - 2,522,326 shares; 1996 - 2,561,344 shares)                 (13,488)            (11,874)
    Unallocated stock in Employee Stock Ownership Plan
        (1997 - 693,120 shares; 1996 - 743,462 shares)                                 (4,592)             (4,925)
                                                                               --------------        ------------
                                                                                      710,928             615,316
                                                                                -------------         -----------
                                                                                  $10,155,520          $8,263,205
                                                                                  ===========          ==========

</TABLE>

SEE NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

                                        4

<PAGE>
<TABLE>
<CAPTION>


                                            PROTECTIVE LIFE CORPORATION
                                  CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
                                              (Dollars in thousands)
                                                    (Unaudited)
                                                                                                NINE MONTHS ENDED
                                                                                                    SEPTEMBER 30
                                                                                                1997            1996
                                                                                                ----            ----
CASH FLOWS FROM OPERATING ACTIVITIES
<S>                                                                                            <C>            <C>        
  Net income                                                                                   $82,747        $64,391
  Adjustments to reconcile net income to net cash provided by
     operating activities:
        Amortization of deferred policy acquisition costs                                       67,561         70,162
        Capitalization of deferred policy acquisition costs                                    (88,154)       (70,124)
        Depreciation expense                                                                     1,946          5,114
        Deferred income taxes                                                                  (20,349)        (4,659)
        Accrued income taxes                                                                    16,637         (1,319)
        Interest credited to universal life and investment products                            357,880        206,763
        Policy fees assessed on universal life and investment products                         (97,491)       (84,362)
        Change in accrued investment income and other receivables                              (34,468)       (78,861)
        Change in policy liabilities and other policyholders' funds
          of traditional life and health products                                               (5,602)        53,996
        Change in other liabilities                                                            (10,515)         8,619
        Other (net)                                                                            (23,341)       (11,792)
                                                                                        --------------   ------------
  Net cash provided by operating activities                                                    246,851        157,928
                                                                                         -------------    -----------

CASH FLOWS FROM INVESTING ACTIVITIES
  Maturities and principal reductions of investments
        Investments available for sale                                                       4,670,040        494,088
        Other                                                                                  225,427         94,816
  Sale of investments
        Investments available for sale                                                       1,062,668        769,357
        Other                                                                                  689,043        561,440
  Cost of investments acquired
        Investments available for sale                                                      (6,547,985)    (2,112,193)
        Other                                                                                 (582,300)      (335,397)
  Acquisitions and bulk reinsurance assumptions                                               (171,560)       172,726
  Purchase of property and equipment                                                            (3,594)        (6,040)
  Sale of property and equipment                                                                 2,681            455
                                                                                        --------------  -------------
  Net cash used in investing activities                                                       (655,580)      (360,748)
                                                                                         -------------    -----------

CASH FLOWS FROM FINANCING ACTIVITIES
  Proceeds from borrowings under line of credit arrangements and debt                        1,202,938        840,484
  Principal payments on line of credit arrangements and debt                                (1,245,338)      (816,984)
  Issuance of Common Stock                                                                                     70,538
  Issuance of preferred securities                                                              75,000
  Dividends to stockholders                                                                    (17,874)       (15,343)
  Investment product deposits and changes in universal life deposits                           771,793        842,765
  Investment product withdrawals                                                              (498,531)      (711,826)
                                                                                         -------------   ------------
  Net cash provided by financing activities                                                    287,988        209,634
                                                                                         -------------   ------------

INCREASE (DECREASE) IN CASH                                                                   (120,741)         6,814
CASH AT BEGINNING OF PERIOD                                                                    121,051         11,392
                                                                                         -------------  -------------
CASH AT END OF PERIOD                                                                   $          310   $     18,206
                                                                                        ==============   ============

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
  Cash paid during the period: 
     Interest on debt                                                                       $  (11,264)    $   (9,389)
     Income taxes                                                                           $  (40,585)    $  (38,971)

SUPPLEMENTAL SCHEDULE OF NONCASH INVESTING AND
  FINANCING ACTIVITIES
  Reissuance of treasury stock to ESOP                                                      $       84     $      669
  Unallocated stock in ESOP                                                                 $      333     $      334
  Reissuance of treasury stock                                                              $    1,096     $      258
  Acquisitions
     Assets acquired                                                                        $1,115,171     $  200,737
     Liabilities assumed                                                                      (902,357)      (253,480)
                                                                                           ------------    -----------
     Net                                                                                    $  212,814     $  (52,743)
                                                                                           ===========     ===========


</TABLE>

SEE NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

                                        5

<PAGE>



                           PROTECTIVE LIFE CORPORATION

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (UNAUDITED)


NOTE A - BASIS OF PRESENTATION

         The accompanying  unaudited consolidated condensed financial statements
of Protective Life  Corporation (the "Company") have been prepared in accordance
with generally accepted accounting  principles for interim financial information
and with  the  instructions  to Form  10-Q and  Rule  10-01 of  Regulation  S-X.
Accordingly,  they do not include all of the  disclosures  required by generally
accepted accounting principles for complete financial statements. In the opinion
of  management,  all  adjustments  (consisting  of  normal  recurring  accruals)
necessary for a fair presentation have been included.  Operating results for the
nine-month  period ended September 30, 1997, are not  necessarily  indicative of
the results  that may be expected for the year ending  December  31,  1997.  The
year-end  consolidated  condensed  balance  sheet data was derived  from audited
financial statements, but does not include all disclosures required by generally
accepted  accounting   principles.   For  further  information,   refer  to  the
consolidated  financial  statements and notes thereto  included in the Company's
annual report on Form 10-K for the year ended December 31, 1996.

NOTE B - COMMITMENTS AND CONTINGENT LIABILITIES

         The Company is  contingently  liable to obtain a $20 million  letter of
credit under indemnity  agreements with its directors.  Such agreements  provide
insurance  protection  in  excess  of the  directors'  and  officers'  liability
insurance in force at the time up to $20 million.  Should  certain  events occur
constituting  a change in control of the  Company,  the Company  must obtain the
letter of credit upon which  directors may draw for defense or settlement of any
claim  relating to  performance  of their duties as  directors.  The Company has
similar  agreements with certain of its officers  providing up to $10 million in
indemnification  which are not secured by the  obligation  to obtain a letter of
credit.

         Under insurance guaranty fund laws in most states,  insurance companies
doing business therein can be assessed up to prescribed  limits for policyholder
losses  incurred  by  insolvent  companies.  The Company  does not believe  such
assessments  will be materially  different from amounts already  provided for in
the  financial  statements.  Most of these  laws do  provide,  however,  that an
assessment  may be excused or deferred if it would  threaten  an  insurer's  own
financial strength.

         A number of civil jury  verdicts  have been  returned  against life and
health  insurers  in the  jurisdictions  in  which  the  Company  does  business
involving the insurers' sales practices,  alleged agent  misconduct,  failure to
properly supervise agents,  and other matters.  Increasingly these lawsuits have
resulted in the award of  substantial  judgments  against  the insurer  that are
disproportionate  to the actual damages,  including material amounts of punitive
damages. In some states (including Alabama),  juries have substantial discretion
in awarding  punitive  damages which  creates the  potential  for  unpredictable
material  adverse  judgments in any given punitive damages suit. The Company and
its subsidiaries, like other life and health insurers, in the ordinary course of
business,  are involved in such  litigation,  including  purported  class action
litigation.  The  outcome  of any  such  litigation  cannot  be  predicted  with
certainty.  In addition,  in some lawsuits involving  insurers' sales practices,
insurers have made material settlement payments to end litigation.

                                        6

<PAGE>



         Although  the  outcome  of any  litigation  cannot  be  predicted  with
certainty, the Company believes that at the present time there are no pending or
threatened lawsuits that are reasonably likely to have a material adverse effect
on the financial position, results of operations, or liquidity of the Company.

NOTE C - PREFERRED SECURITIES

         In 1994 a  special  purpose  finance  subsidiary  of the  Company,  PLC
Capital  L.L.C.  ("PLC  Capital"),  issued $55 million of 9% Cumulative  Monthly
Income  Preferred  Securities,  Series A ("MIPS").  On April 29,  1997,  another
special  purpose finance  subsidiary,  PLC Capital Trust I ("PLC Capital Trust")
issued $75 million of 8.25% Trust Originated Preferred Securities ("TOPrS"). The
MIPS and TOPrS are  guaranteed  on a  subordinated  basis by the  Company.  This
guarantee,  considered  together with the other  obligations of the Company with
respect to the MIPS and TOPrS, constitutes a full and unconditional guarantee by
the Company of PLC Capital and PLC Capital Trust's  obligations  with respect to
the MIPS and TOPrS.

         PLC  Capital  and  PLC  Capital  Trust  were  formed  solely  to  issue
securities and use the proceeds thereof to purchase  subordinated  debentures of
the Company. The sole assets of PLC Capital are $69.6 million of Protective Life
Corporation  9% Series A  Subordinated  Debentures  due June 30, 2024.  The sole
assets of PLC Capital  Trust are $77.3 million of  Protective  Life  Corporation
8.25%  Subordinated  Debentures  due 2027,  Series B. The  Company has the right
under the subordinated  debentures to extend interest payment periods up to five
consecutive years, and, as a consequence, dividends on the MIPS and TOPrS may be
deferred (but will continue to accumulate, together with additional dividends on
any  accumulated  but unpaid  dividends at the dividend rate) by PLC Capital and
PLC Capital  Trust,  respectively,  during any such  extended  interest  payment
period.  The MIPS are redeemable by PLC Capital at any time on or after June 30,
1999.  The TOPrS are  redeemable  by PLC  Capital  Trust at any time on or after
April 29, 2002.

         The MIPS and TOPrS are reported in the  accompanying  balance sheets as
"Guaranteed Preferred Beneficial Interests In Company's Subordinated Debentures"
and the related dividends are reported in the accompanying  statements of income
as "minority interest in net income of consolidated subsidiaries".



                                        7

<PAGE>



NOTE D - BUSINESS SEGMENTS

         The Company operates  predominantly in the life and accident and health
insurance industry. The following table sets forth total revenues, income (loss)
before  income  tax  and  minority  interest,  and  identifiable  assets  of the
Company's business segments.
<TABLE>
<CAPTION>

                                                                         NINE MONTHS ENDED SEPTEMBER 30
                                                                 1997                                  1996
                                                                 ----                                  ----
                                                        AMOUNT           PERCENT               AMOUNT          PERCENT
                                                                          (dollars in thousands)
<S>                                                  <C>                <C>                  <C>               <C>
TOTAL REVENUES:
  Acquisitions                                       $168,054           20.7  %              $157,565          20.4%
  Dental and Consumer Benefits                        158,137           19.5                  151,767          19.7
  Financial Institutions                               41,212            5.1                   69,453           9.0
  Guaranteed Investment Contracts                     155,876           19.2                  153,720          19.9
  Individual Life                                     165,945           20.4                  133,958          17.4
  Investment Products                                  91,405           11.2                   85,949          11.1
  Corporate and Other                                  29,828            3.7                   13,871           1.8
  Unallocated Realized
     Investment Gains (Losses)                          2,037            0.2                    5,790           0.7
                                                   ----------         ------               ----------        ------
                                                     $812,494          100.0  %              $772,073         100.0%
                                                     ========          =====                 ========         =====

INCOME (LOSS) BEFORE INCOME
  TAX AND MINORITY INTEREST:
  Acquisitions                                       $ 45,033           34.2  %              $ 38,252          37.8%
  Dental and Consumer Benefits                         14,103           10.7                    2,821           2.8
  Financial Institutions                                9,197            7.0                    6,893           6.8
  Guaranteed Investment Contracts                      20,082           15.3                   22,299          22.0
  Individual Life                                      14,778           11.2                   11,502          11.4
  Investment Products                                   8,577            6.5                    9,822           9.7
  Corporate and Other                                  17,796           13.5                    3,840           3.8
  Unallocated Realized
     Investment Gains (Losses)                          2,037            1.6                    5,790           5.7
                                                   ----------         ------               ----------        ------
                                                     $131,603          100.0  %              $101,219         100.0%
                                                     ========          =====                 ========         =====

                                                          SEPTEMBER 30, 1997                     DECEMBER 31, 1996
                                                      AMOUNT             PERCENT               AMOUNT          PERCENT
                                                                        (dollars in thousands)
IDENTIFIABLE ASSETS:
  Acquisitions                                    $ 1,507,191           14.8  %            $1,579,253          19.1%
  Dental and Consumer Benefits                        294,759            2.9                  278,926           3.4
  Financial Institutions                              467,542            4.6                  352,021           4.3
  Guaranteed Investment Contracts                   2,973,521           29.3                2,608,149          31.5
  Individual Life                                   2,100,872           20.7                1,037,386          12.5
  Investment Products                               2,324,258           22.9                1,873,119          22.7
  Corporate and Other                                 487,377            4.8                  534,351           6.5
                                                -------------         ------              -----------        ------
                                                  $10,155,520          100.0  %            $8,263,205         100.0%
                                                  ===========          =====               ==========         =====

</TABLE>

NOTE E - STATUTORY REPORTING PRACTICES

         Financial  statements  prepared in conformity  with generally  accepted
accounting  principles  ("GAAP")  differ  in some  respects  from the  statutory
accounting   practices   prescribed   or  permitted   by  insurance   regulatory
authorities.  At  September  30, 1997 and for the nine  months  then ended,  the
Company's life insurance  subsidiaries had  stockholder's  equity and net income
prepared in conformity with statutory  reporting practices of $417.2 million and
$84.9 million, respectively.


                                        8

<PAGE>



NOTE F - INVESTMENTS

         As prescribed by Statement of Financial  Accounting  Standards ("SFAS")
No.  115,  certain  investments  are  recorded at their  market  values with the
resulting  unrealized  gains  and  losses  reduced  by a related  adjustment  to
deferred policy acquisition costs, net of income tax, reported as a component of
stockholders' equity. The market values of fixed maturities increase or decrease
as interest rates fall or rise. Therefore, although the adoption of SFAS No. 115
does not affect the Company's operations, its reported stockholders' equity will
fluctuate significantly as interest rates change.

         The  Company's  balance  sheets at September  30, 1997 and December 31,
1996,  prepared on the basis of reporting  investments  at amortized cost rather
than at market values, are as follows:
<TABLE>
<CAPTION>

                                                            SEPTEMBER 30, 1997                   DECEMBER 31, 1996
                                                            ------------------                   -----------------
                                                                              (IN THOUSANDS)

<S>                                                          <C>                                  <C>       
        Total investments                                    $  7,839,655                         $6,534,122
        Deferred policy acquisition costs                         646,852                            496,148
        All other assets                                        1,609,120                          1,222,646
                                                             ------------                         ----------
                                                              $10,095,627                         $8,252,916
                                                              ===========                         ==========

        Deferred income taxes                              $       13,919                        $    34,268
        All other liabilities                                   9,278,534                          7,555,020
                                                             ------------                         ----------
                                                                9,292,453                          7,589,288
        Preferred Securities                                      130,000                             55,000
        Stockholders' equity                                      673,174                            608,628
                                                            -------------                        -----------
                                                              $10,095,627                         $8,252,916
                                                              ===========                         ==========

</TABLE>

NOTE G - ACCOUNTING POLICIES FOR DERIVATIVE FINANCIAL INSTRUMENTS

         The Company does not use derivative  financial  instruments for trading
purposes.  Combinations  of futures  contracts and options on treasury notes are
currently  being  used as  hedges  for  asset/liability  management  of  certain
investments,   primarily   mortgage   loans  on  real  estate,   mortgage-backed
securities,  and liabilities  arising from  interest-sensitive  products such as
guaranteed  investment  contracts and annuities.  Realized  investment gains and
losses on such  contracts are deferred and amortized over the life of the hedged
asset.  At September 30, 1997,  open option  contracts with a notional amount of
$1.2 billion were in a $1.1 million unrealized loss position.

         The  Company  uses  interest  rate swap  contracts  to convert  certain
investments  from a variable to a fixed rate of interest.  The Company also uses
interest  rate swap  contracts  and  options to enter into  interest  rate swaps
(swaptions) to convert a portion of its Senior Notes,  Medium-Term  Notes, MIPS,
and TOPrS from a fixed rate to a variable  rate of interest.  The proceeds  from
the sale of swaptions  are deferred and  amortized  over the life of the related
securities.  At September 30, 1997,  related open  interest rate swap  contracts
with a notional  amount of $460.3  million were in a $0.9 million net unrealized
gain position.



                                        9

<PAGE>



NOTE H - RECENTLY ISSUED ACCOUNTING STANDARDS

         In June 1996 the Financial  Accounting Standards Board issued Statement
of  Financial  Accounting  Standards  No. 125,  "Accounting  for  Transfers  and
Servicing  of  Financial  Assets  and  Extinguishments  of  Liabilities".   This
statement is effective for transactions entered into after January 1, 1997.

NOTE I - RECLASSIFICATIONS

         Certain  reclassifications  have been made in the  previously  reported
financial  statements  and  accompanying  notes to make the prior  year  amounts
comparable to those of the current year. Such reclassifications had no effect on
previously reported net income, total assets or stockholders' equity.


                                       10

<PAGE>



            ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                       CONDITION AND RESULTS OF OPERATIONS


         Protective  Life  Corporation,   through  its  subsidiaries,   provides
financial services through the production,  distribution,  and administration of
insurance and investment  products.  Founded in 1907,  Protective Life Insurance
Company ("Protective Life") is the Company's principal operating subsidiary.

         Unless the context  otherwise  requires,  the  "Company"  refers to the
consolidated group of Protective Life Corporation and its subsidiaries.

         The  Company  has six  operating  divisions:  Acquisitions,  Dental and
Consumer Benefits  ("Dental"),  Financial  Institutions,  Guaranteed  Investment
Contracts ("GIC"),  Individual Life, and Investment  Products.  The Company also
has an additional  business  segment which is described  herein as Corporate and
Other.

         The Dental Division  (formerly  known as the Group  Division)  recently
exited  from the  traditional  group  major  medical  business,  fulfilling  the
Division's   strategy  to  focus  primarily  on  dental  and  related  products.
Accordingly, the Division was renamed the Dental and Consumer Benefits Division.

                              RESULTS OF OPERATIONS

PREMIUMS AND POLICY FEES

         The  following  table  sets forth for the  periods  shown the amount of
premiums and policy fees and the percentage change from the prior period:

                                 PREMIUMS AND POLICY FEES
                NINE MONTHS                                    PERCENTAGE
                 ENDED                   AMOUNT                 INCREASE/
                 SEPTEMBER 30          (IN THOUSANDS)          (DECREASE)

                   1996                 $366,533                 12.8 %
                   1997                  363,817                 (0.7)

         Premiums  and policy fees  decreased  $2.7 million or 0.7% in the first
nine months of 1997 over the first nine months of 1996.  The  coinsurance by the
Acquisitions Division of a block of policies and the acquisition of a small life
insurance  company in the  fourth  quarter of 1996  resulted  in a $6.1  million
increase  in  premiums  and policy  fees.  Decreases  in older  acquired  blocks
resulted in a $6.0  million  decrease in premiums  and policy  fees.  The Dental
Division's  exit from the  group  major  medical  business  resulted  in a $22.4
million  decrease in premiums and policy fees.  Premiums and policy fees related
to the Dental  Division's other businesses  increased $26.2 million in the first
nine months of 1997 as compared to the same period in 1996.  Premiums and policy
fees from the Financial  Institutions  Division  decreased  $27.1 million in the
first  nine  months  of 1997 as  compared  to the  first  nine  months  of 1996.
Decreases of $12.8 million resulted from a reinsurance arrangement begun in 1995
whereby most of the Division's new credit insurance sales are being ceded to a

                                       11

<PAGE>



reinsurer.  Decreases of $14.3 million relate to the normal decrease in premiums
on a closed block of credit insurance policies reinsured in 1996. The Individual
Life Division's premiums and policy fees increased $16.0 million, including $6.4
million from the acquisition of West Coast Life Insurance Company ("West Coast")
in the second quarter of 1997. The increase in premiums and policy fees from the
Investment Products Division was $2.7 million.

NET INVESTMENT INCOME

         The following  table sets forth for the periods shown the amount of net
investment income and the percentage change from the prior period:

         NINE MONTHS                              NET INVESTMENT INCOME
            ENDED                           AMOUNT                  PERCENTAGE
        SEPTEMBER 30                      (IN THOUSANDS)            INCREASE

           1996                             $384,149                   8.3%
           1997                              426,001                  10.9

         Net  investment  income  in the  first  nine  months  of 1997 was $41.9
million or 10.9%  higher than the  corresponding  period of the  preceding  year
primarily  due to  increases  in the average  amount of  invested  assets and an
increase in participating  mortgage loan income.  Invested assets have increased
primarily  due to  receiving  annuity  deposits  and  due to  acquisitions.  The
coinsurance of a block of policies and the acquisition of a small life insurance
company in the fourth  quarter of 1996 and the  acquisition of West Coast in the
second quarter of 1997 resulted in an increase in net investment income of $24.9
million in the first nine months of 1997 as compared to the same period in 1996.

REALIZED INVESTMENT GAINS

         The Company generally purchases its investments with the intent to hold
to  maturity  by  purchasing  investments  that match  future  cash-flow  needs.
However,  the Company may sell any of its  investments  to maintain  approximate
matching of assets and liabilities.  Accordingly, the Company has classified its
fixed maturities and certain other securities as "available for sale." The sales
of  investments  that have  occurred have resulted  principally  from  portfolio
management decisions to maintain approximate matching of assets and liabilities.

         The following  table sets forth net realized  investment  gains for the
periods shown:

          NINE MONTHS                                    NET REALIZED
             ENDED                                     INVESTMENT GAINS
         SEPTEMBER 30                                   (IN THOUSANDS)

            1996                                             $5,882
            1997                                                786

         Net  realized  investment  gains were $0.8  million  for the first nine
months of 1997 compared to $5.9 million for the corresponding period of 1996. In
the 1996 first quarter,  the Company  reported a $6.1 million gain relating to a
securitization transaction.

                                       12

<PAGE>




OTHER INCOME

         The following table sets forth other income for the periods shown:

         NINE MONTHS
            ENDED                                    OTHER INCOME
        SEPTEMBER 30                                (IN THOUSANDS)

            1996                                        $15,509
            1997                                         21,890

         Other  income   consists   primarily  of  revenues  of  the   Company's
broker-dealer subsidiary, fees from variable insurance products, revenues of the
Company's wholly-owned insurance marketing  organizations and small noninsurance
subsidiaries,  and the results of the Company's  50%-owned joint venture in Hong
Kong. Other income in the first nine months of 1997 was $6.4 million higher than
the  corresponding  period of 1996.  Revenues from the  Company's  broker-dealer
subsidiary  increased  $4.1 million in the first nine months of 1997 as compared
to the same period in 1996.  Other income from all other sources  increased $2.3
million in the first nine months of 1997 as compared  with the first nine months
of 1996.

INCOME BEFORE INCOME TAX AND MINORITY INTEREST

         The  following  table sets forth  income or loss before  income tax and
minority interest by business segment for the periods shown:
<TABLE>
<CAPTION>

                                                                                       INCOME (LOSS) BEFORE INCOME TAX
                                                                                         AND MINORITY INTEREST
                                                                                        NINE MONTHS ENDED SEPTEMBER 30
                                                                                            (IN THOUSANDS)
                BUSINESS SEGMENT                                                1997                         1996
                ----------------                                                ----                         ----

<S>                                                                         <C>                            <C>     
        Acquisitions                                                        $  45,033                      $ 38,252
        Dental and Consumer Benefits                                           14,103                         2,821
        Financial Institutions                                                  9,197                         6,893
        Guaranteed Investment Contracts                                        20,082                        22,299
        Individual Life                                                        14,778                        11,502
        Investment Products                                                     8,577                         9,822
        Corporate and Other                                                    17,796                         3,840
        Unallocated Realized Investment Gains                                   2,037                         5,790
                                                                           ----------                    ----------
                                                                             $131,603                      $101,219
                                                                             ========                      ========

        Percentage Increase                                                   30.0%                         11.1%

</TABLE>

                                       13

<PAGE>



         Pretax earnings from the Acquisitions  Division  increased $6.8 million
in the  first  nine  months  of 1997 as  compared  to the same  period  of 1996.
Earnings from the  Acquisitions  Division are normally  expected to decline over
time (due to the  lapsing of  policies  resulting  from  deaths of  insureds  or
terminations of coverage)  unless new acquisitions are made. The Division's most
recent acquisitions  resulted in a $3.3 million increase in pretax earnings.  In
addition,  the Division's  mortality  experience was approximately  $7.2 million
more  favorable  in the first nine months of 1997 as compared to the same period
last year.

         Dental  Division  pretax earnings were $4.5 million higher in the first
nine months of 1997 as  compared  to the first nine  months of 1996  excluding a
$6.8 million refund of premiums and related  expenses in the 1996 third quarter.
Dental earnings were $8.3 million, an increase of $1.6 million,  before expenses
of $1.8 million to develop a new discounted fee-for-service dental program. $1.8
million of the  increase  was a one-time  release of  reserves  associated  with
exiting the group major medical business. Lower cancer earnings partially offset
improved results in other lines.

         Pretax  earnings  of the  Financial  Institutions  Division  were  $2.3
million  higher in the first nine  months of 1997 as compared to the same period
in 1996. Included in the Division's results are earnings from the coinsurance of
a block of policies in the second quarter of 1996.

         The GIC Division had pretax operating  earnings of $21.9 million in the
first nine months of 1997 and $30.1 million in the corresponding period of 1996.
The decline largely  reflects a reallocation  of investment  income from the GIC
Division to the Company's  other  divisions and Corporate and Other segment.  In
December 1996, the Company sold a major portion of its bank loan  participations
in a securitization  transaction which has reduced the Division's earnings.  The
decrease  was  partially  offset by a related  improvement  in  earnings  in the
Corporate and Other segment. In addition, the Company has shortened the duration
of the GIC Division's invested assets which also reduced earnings and lengthened
the duration of the other  divisions'  invested assets to better match assets to
liabilities on a divisional  level.  Realized  investment losses associated with
this  Division in the first nine months of 1997 were $1.8 million as compared to
$7.8 million in the same period last year.  As a result,  total pretax  earnings
were $20.1  million in the first nine months of 1997  compared to $22.3  million
for the same period last year.

         The Individual  Life  Division's  results  include West Coast which the
Company acquired on June 3. The Division's  pretax  operating  earnings of $14.8
million in the first nine months of 1997 were $4.4 million above the same period
of 1996. West Coast represents $3.0 million of the increase.  Mortality returned
to normal  levels in the 1997  third  quarter  after  experiencing  record  high
mortality in the previous  quarter which  reduced  earnings  approximately  $4.3
million.  Realized  investment  gains,  net of related  amortization of deferred
policy  acquisition  costs,  associated  with this Division were $1.1 million in
1996.  As a result,  total pretax  earnings were $14.8 million in the first nine
months of 1997 as compared to $11.5 million in the first nine months of 1996.

         Investment  Products Division pretax operating earnings of $8.4 million
were $1.0 million  higher in the first nine months of 1997  compared to the same
period of 1996.  The  Division's  1996 results  included a one-time $0.9 million
addition to earnings.  Realized  investment  gains associated with the Division,
net of related  amortization of deferred  policy  acquisition  costs,  were $0.2
million in the first nine months of 1997 as  compared  to $2.4  million in 1996,
resulting in total  pretax  earnings of $8.6 million in the first nine months of
1997 as compared to $9.8 million in the same period of 1996.

                                       14

<PAGE>



         The Corporate and Other segment  consists  primarily of net  investment
income on capital,  interest  expense on  substantially  all debt, the Company's
50%-owned joint venture in Hong Kong, several small insurance lines of business,
and the operations of several small noninsurance  subsidiaries.  Pretax earnings
for this  segment  increased  $14.0  million in the first nine months of 1997 as
compared  to the first  nine  months of 1996.  In the 1997  second  quarter  the
Company  sold its  interest in a money  management  joint  venture  resulting in
income of $4.1  million.  In the 1997 third quarter the segment had $3.0 million
of income from the Company's participation  commercial mortgage loan program. In
addition,  the segment's  results include a decrease in interest expense of $2.6
million  representing the dividends on the Company's Trust Originated  Preferred
Securities   which  are  reported  as  "minority   interest  in  net  income  of
consolidated  subsidiaries"  rather than as expenses of the  Corporate and Other
segment.  The remaining  increase in earnings relates primarily to increased net
investment income on capital and income from a securitization transaction.

INCOME TAXES

         The following  table sets forth the effective  income tax rates for the
periods shown:
                     NINE MONTHS
                     ENDED                            ESTIMATED EFFECTIVE
                    SEPTEMBER 30                        INCOME TAX RATES

                      1996                                     34%
                      1997                                     34

         The  effective  income  tax  rate  for the  full  year of 1996 was 34%.
Management's estimate of the effective income tax rate for 1997 is also 34%.

NET INCOME

         The following  table sets forth net income and the net income per share
for the periods shown, and the percentage change from the prior period:

            NINE MONTHS                          NET INCOME
               ENDED                    TOTAL                         PERCENTAGE
            SEPTEMBER 30            (IN THOUSANDS)       PER SHARE     INCREASE
           ------------             -------------        ---------     ---------

              1996                     $64,391             $2.15          5.9%
              1997                      82,747              2.65         23.3

         Compared to the same period in 1996,  net income per share in the first
nine months of 1997 increased 23.3%,  reflecting  improved operating earnings in
the Acquisitions, Dental, Financial Institutions, Individual Life and Investment
Products  Divisions and the Corporate and Other  segment,  which were  partially
offset  by lower  operating  earnings  in the  Guaranteed  Investment  Contracts
Division and lower realized  investment  gains (net of related  amortization  of
deferred policy acquisition costs).


                                       15

<PAGE>



RECENTLY ISSUED ACCOUNTING STANDARDS

         In February  1997 the Financial  Accounting  Standards  Board  ("FASB")
issued Statement of Financial  Accounting  Standards ("SFAS") No. 128, "Earnings
per Share,"  effective for financial  statements issued for periods ending after
December  15,  1997.  In June  1997 the FASB  issued  SFAS No.  130,  "Reporting
Comprehensive  Income,"  and SFAS No.  131,  "Disclosures  about  Segments of an
Enterprise and Related  Information,"  effective for financial statements issued
for periods beginning after December 15, 1997. The Company  anticipates that the
impact of adopting these accounting standards will not be significant.


                         LIQUIDITY AND CAPITAL RESOURCES

         The Company's  operations  usually  produce a positive cash flow.  This
cash flow is used to fund an  investment  portfolio  to finance  future  benefit
payments.  Since future benefit payments largely represent medium- and long-term
obligations  reserved  using  certain  assumed  interest  rates,  the  Company's
investments are predominantly in medium- and long-term,  fixed-rate  investments
such as bonds and mortgage loans.

         Many of the  Company's  products  contain  surrender  charges and other
features  that reward  persistency  and penalize the early  withdrawal of funds.
Surrender  charges for these  products  generally  are  sufficient  to cover the
Company's  unamortized  deferred  policy  acquisition  costs with respect to the
policy being  surrendered.  GICs and certain annuity contracts have market-value
adjustments that protect the Company against investment losses if interest rates
are higher at the time of surrender than at the time of issue.

         The Company's investments in debt and equity securities are reported at
market value,  and investments in mortgage loans are reported at amortized cost.
At  September  30,  1997,  the  fixed  maturity  investments  (bonds,  bank loan
participations,  and redeemable preferred stocks) had a market value of $6,157.6
million,  which is 1.4% above amortized cost (less allowances for  uncollectible
amounts on investments) of $6,072.0 million. The Company had $1,261.8 million in
mortgage loans at September 30, 1997. While the Company's  mortgage loans do not
have quoted  market  values,  at September 30, 1997,  the Company  estimates the
market value of its mortgage loans to be $1,339.8 million (using discounted cash
flows from the next call date) which is 6.2% in excess of amortized  book value.
Most of the Company's  mortgage  loans have  significant  prepayment  penalties.
These assets are invested for terms  approximately  corresponding to anticipated
future benefit payments.  Thus, market value  fluctuations  should not adversely
affect liquidity.

         For several  years the Company  has offered a type of  commercial  loan
under which the Company  will permit a slightly  higher  loan-to-value  ratio in
exchange for a participating interest in the cash flows from the underlying real
estate.  Approximately  $487.7 million of the Company's mortgage loans have this
participation feature.

         At September 30, 1997,  delinquent  mortgage loans and foreclosed  real
estate were 0.2% of assets.  Bonds rated less than investment grade were 1.9% of
assets.  Additionally,  the Company had bank loan  participations that were less
than investment grade  representing 0.2% of assets.  The Company does not expect
these  investments  to  adversely  affect its  liquidity  or ability to maintain
proper  matching  of  assets  and  liabilities.   The  Company's  allowance  for
uncollectible amounts on

                                       16

<PAGE>



investments was $24.7 million at September 30, 1997.

         Policy loans at September 30, 1997, were $194.2 million,  a decrease of
$3.4 million from December 31, 1996 (after excluding approximately $30.9 million
of policy loans  associated  with an acquisition in the second quarter of 1997).
Policy loan rates are generally in the 4.5% to 8.0% range and are at least equal
the assumed interest rates used for future policy benefits.

         The  Company  believes  its  asset/liability  management  programs  and
procedures and certain product features provide  significant  protection for the
Company against the effects of changes in interest rates. However, approximately
one-fourth of the Company's liabilities relate to products (primarily whole life
insurance)  the  profitability  of which may be  affected by changes in interest
rates.  The  effect  of such  changes  in any one  year  is not  expected  to be
material.  Additionally,  the Company  believes its  asset/liability  management
programs and procedures provide sufficient liquidity to enable it to fulfill its
obligation to pay benefits under its various insurance and deposit contracts.

         The  Company's  asset/liability   management  programs  and  procedures
involve the  monitoring  of asset and liability  durations  for various  product
lines;  cash  flow  testing  under  various  interest  rate  scenarios;  and the
continuous  rebalancing of assets and liabilities  with respect to yield,  risk,
and cash flow characteristics.  It is the Company's policy to generally maintain
asset and liability durations within one half year of one another, although from
time to time broader duration matching is allowed.

         The Company does not use derivative  financial  instruments for trading
purposes. Combinations of futures contracts, interest rate options, and interest
rate  swaps are  sometimes  used as hedges  for  asset/liability  management  of
certain  investments,  primarily mortgage loans on real estate,  mortgage-backed
securities,  and liabilities  arising from  interest-sensitive  products such as
GICs and annuities.  Realized  investment gains and losses of such contracts are
deferred and amortized over the life of the hedged asset. At September 30, 1997,
open option  contracts  with a notional  amount of $1.2  billion  were in a $1.1
million unrealized loss position.

         The Company may also  sometimes  use interest  rate swap  contracts and
options  to enter  into  interest  rate swap  contracts  (swaptions)  to convert
certain investments from a variable to a fixed rate of interest and from a fixed
to a variable  rate of interest,  and to convert a portion of its Senior  Notes,
Medium-Term  Notes,  Monthly Income Preferred  Securities,  and Trust Originated
Preferred  Securities  from a fixed rate to a  variable  rate of  interest.  The
proceeds from the sale of swaptions are deferred and amortized  over the life of
the related  debt.  At September  30,  1997,  related  open  interest  rate swap
contracts  with a notional  amount of $460.3  million were in a $0.9 million net
unrealized gain position.

         Withdrawals  related to GICs were  approximately  $786  million  during
1996. Withdrawals related to GICs are estimated to be approximately $600 million
in 1997. The Company's  asset/liability  management programs and procedures take
into  account  maturing  contracts.  Accordingly,  the  Company  does not expect
maturing  contracts  to have an  unusual  effect on the  future  operations  and
liquidity of the Company.

         In  anticipation  of  receiving  GIC and  annuity  deposits,  the  life
insurance  subsidiaries  were  committed at September 30, 1997, to fund mortgage
loans and to purchase  fixed  maturity and other  long-term  investments  in the
amount of $426.0 million. The Company's subsidiaries held $199.8

                                       17

<PAGE>



million in cash and  short-term  investments  at September 30, 1997.  Protective
Life  Corporation  had  an  additional  $2.9  million  in  cash  and  short-term
investments available for general corporate purposes.

         While the  Company  generally  anticipates  that the cash  flows of its
subsidiaries  will  be  sufficient  to meet  their  investment  commitments  and
operating  cash  needs,  the  Company  recognizes  that  investment  commitments
scheduled  to be funded may from time to time  exceed the funds then  available.
Therefore,  the  Company  has  arranged  sources  of  credit  for its  insurance
subsidiaries  to use when needed.  The Company expects that the rate received on
its  investments  will equal or exceed its  borrowing  rate.  Additionally,  the
Company may from time to time sell  short-duration  GICs to complement  its cash
management practices.

         On April 29, 1997, a special purpose finance subsidiary of the Company,
PLC  Capital  Trust I ("PLC  Capital  Trust")  issued $75 million of 8.25% Trust
Originated Preferred Securities ("TOPrS"), guaranteed on a subordinated basis by
the  Company.  PLC  Capital  Trust was  formed  solely to issue  TOPrS and other
securities and use the proceeds thereof to purchase  subordinated  debentures of
the  Company.  The Company has the right under the  subordinated  debentures  to
extend  interest  payment  periods  up to 20  consecutive  quarters,  and,  as a
consequence, quarterly dividends on the TOPrS may be deferred (but will continue
to accumulate,  together with additional dividends on any accumulated but unpaid
dividends at the dividend  rate) by PLC Capital  Trust during any such  extended
interest  payment  period.  The TOPrS are redeemable by PLC Capital Trust at any
time on or after April 29, 2002.  Net proceeds of  approximately  $72.6  million
were used to repay bank borrowings. In related transactions, the Company entered
into interest rate swap agreements which effectively  converted the TOPrS from a
fixed  dividend  rate to the  floating  90 day  London  Interbank  Offered  Rate
("LIBOR")  plus 74 basis points.  The  effective  interest rate at September 30,
1997, was 6.46%.

         On September 15, 1997, the Company sold  approximately  $445 million of
its commercial mortgage loans in a securitization transaction. Proceeds from the
sale  consisted of cash of  approximately  $328  million,  net of expenses,  and
securities  issued  in the  securitization  transaction  of  approximately  $110
million.

         At September 30, 1997,  Protective  Life  Corporation had borrowed $7.1
million  of a $70  million  revolving  line of  credit  bearing  interest  rates
averaging 6.1% and an additional $11.5 million at a rate of 5.9%.

         Protective Life  Corporation's cash flow is dependent on cash dividends
and payments on surplus notes from its  subsidiaries,  revenues from investment,
data processing,  legal, and management  services  rendered to the subsidiaries,
and  investment  income.  At December  31, 1996,  approximately  $173 million of
consolidated   stockholders'   equity,   excluding  net  unrealized   losses  on
investments, represented net assets of the Company's insurance subsidiaries that
cannot be transferred in the form of dividends,  loans or advances to the parent
company. In addition,  the states in which the Company's insurance  subsidiaries
are domiciled impose certain restrictions on the insurance subsidiaries' ability
to pay dividends to Protective Life Corporation. Also, distributions,  including
cash  dividends  to  Protective  Life   Corporation   from  its  life  insurance
subsidiaries,  in excess of  approximately  $439  million,  would be  subject to
federal income tax at rates then effective.


                                       18

<PAGE>



         Due to the  expected  growth  of the  Company's  insurance  sales,  the
Company  plans  to  retain  substantial  portions  of the  earnings  of its life
insurance  subsidiaries  in those  companies  primarily to support  their future
growth.  Protective Life Corporation's cash disbursements have from time to time
exceeded  its cash  receipts,  and these  shortfalls  have been  funded  through
various  external  financings.  Therefore,  Protective Life Corporation may from
time to time require additional external financing.

         To give the Company  flexibility in connection with future acquisitions
and other growth  opportunities,  the Company has  registered  debt  securities,
preferred  and common  stock and stock  purchase  contracts of  Protective  Life
Corporation,  and additional  preferred  securities of special  purpose  finance
subsidiaries under the Securities Act of 1933 on a delayed (or shelf) basis.

         A life insurance  company's  statutory capital is computed according to
rules  prescribed  by  the  National  Association  of  Insurance   Commissioners
("NAIC"),  as modified by the insurance  company's state of domicile.  Statutory
accounting rules are different from generally accepted accounting principles and
are  intended to reflect a more  conservative  view by, for  example,  requiring
immediate  expensing of policy  acquisition costs. The NAIC's risk-based capital
requirements  require  insurance  companies to calculate and report  information
under a risk-based  capital  formula.  The achievement of long-term  growth will
require growth in the statutory capital of the Company's insurance subsidiaries.
The  subsidiaries  may  secure  additional  statutory  capital  through  various
sources,  such as retained  statutory  earnings or equity  contributions  by the
Company.

         Under insurance guaranty fund laws in most states,  insurance companies
doing business in a participating  state can be assessed up to prescribed limits
for policyholder  losses incurred by insolvent  companies.  The Company does not
believe that any such  assessments  will be  materially  different  from amounts
already reflected in the financial statements.

          The Company and its subsidiaries, like other life and health insurers,
in the course of business  are involved in  litigation.  Although the outcome of
any litigation cannot be predicted with certainty,  the Company believes that at
the present time there are no pending or threatened lawsuits that are reasonably
likely to have a material adverse effect on the financial  position,  results of
operations, or liquidity of the Company.

         Rating  downgrades  have exceeded  upgrades for the past several years,
and public  pronouncements  by the rating  agencies  indicate that this trend is
expected to continue for the near future.

         The  Company  is  not  aware  of any  material  pending  or  threatened
regulatory action with respect to the Company or any of its subsidiaries.

                                       19

<PAGE>



                                     PART II



Item 6.   EXHIBITS AND REPORTS ON FORM 8-K

          (a).   Exhibit 10(a) - Form of Employment Continuation Agreement

                 Exhibit 15 - Letter re: unaudited interim financial statements

                 Exhibit 27 - Financial Data Schedule

                 Exhibit 99 - Safe Harbor for Forward Looking Statements

          (b).   A report on Form 8-K dated July 23, 1997,  was filed  reporting
                 under  Item 5 and Item 7, the  Company's  1997  second  quarter
                 earnings press release.



                                    SIGNATURE


          Pursuant to the  requirements of the Securities  Exchange Act of 1934,
the  registrant  has  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                           PROTECTIVE LIFE CORPORATION




Date: November 12, 1997                           /S/  JERRY W. DEFOOR
                                                  --------------------
                                                  Jerry W. DeFoor
                                                  Vice President and Controller,
                                                  and Chief Accounting Officer
                                                  (Duly authorized officer)

                                       20



                                                                  EXHIBIT 10(A)

                        EMPLOYMENT CONTINUATION AGREEMENT


              THIS AGREEMENT  between  Protective Life  Corporation,  a Delaware
corporation (the "Company"), and (the "Executive"), dated as of this ____ day of
, 1997.


                              W I T N E S S E T H :

              WHEREAS, the Company has employed the Executive in a key executive
officer position and has determined that the Executive holds a position which is
of critical importance to the Company;

              WHEREAS,  the Company believes that, in the event it is confronted
with a situation  that could  result in a change in  ownership or control of the
Company,  continuity of management  will be essential to its ability to evaluate
and respond to such situation in the best interests of shareholders;

              WHEREAS,  the Company  understands  that any such  situation  will
present significant concerns for the Executive with respect to his financial and
job security;

              WHEREAS,  the Company  desires to assure itself of the Executive's
services during the period in which it is confronting  such a situation,  and to
provide the Executive with certain financial  assurances to enable the Executive
to perform the responsibilities of his position without undue distraction and to
exercise his judgment without bias due to his personal circumstances;

              WHEREAS,  to  achieve  these  objectives,   the  Company  and  the
Executive  desire to enter  into an  agreement  providing  the  Company  and the
Executive with certain rights and obligations upon the occurrence of a Change of
Control (as defined in Section 2);

              NOW,  THEREFORE,  in  consideration  of the  premises  and  mutual
covenants herein  contained,  it is hereby agreed by and between the Company and
the Executive as follows:

     1. OPERATION OF AGREEMENT.  (a) EFFECTIVE  DATE. The effective date of this
Agreement  shall be the date on which a Change of Control occurs (the "Change of
Control  Date"),  PROVIDED THAT, if the Executive is not employed by the Company
on the Change of Control Date, this Agreement shall be void and without effect.

     2. DEFINITIONS.(a) CHANGE OF CONTROL. For the purposes of this Agreement, a
"Change of Control" shall mean (I) a transaction or acquisition as identified in
the  Company's  Rights  Agreement as in effect from time to time;  (II) upon the
consummation of any merger,


<PAGE>



consolidation,  or similar  transaction or a purchase of securities  pursuant to
which (x) the members of the Board of Directors of the Company immediately prior
to such  transaction do not,  immediately  after the  transaction,  constitute a
majority  of  the  Board  of  Directors  of the  surviving  entity  or  (y)  the
stockholders  of the  Company  immediately  preceding  the  transaction  do not,
immediately after the transaction, own at least 50% of the combined voting power
of the outstanding  securities of the surviving  entity; or (III) a sale, lease,
exchange  or  other  transfer  (in  one  transaction  or  a  series  of  related
transactions)  of  all  or  substantially  all of  the  assets  of  the  Company
including,  without  limitation any sale, lease,  exchange or other transfer (in
one transaction or a series of related transactions) of all or substantially all
of the assets of Protective Life Insurance Company.

              (b)  POTENTIAL  CHANGE  OF  CONTROL.  For  the  purposes  of  this
Agreement, a Potential Change of Control shall be deemed to have occurred if (I)
the Company enters into an agreement,  the consummation of which would result in
the  occurrence of a Change of Control;  (ii) any person  publicly  announces an
intention to take or to consider  taking actions which,  if  consummated,  would
constitute  a  Change  of  Control;  (iii)  any  person  (other  than any of the
Company's subsidiaries or any employee benefit plan of the Company or any of its
subsidiaries) hereafter becomes the beneficial owner, directly or indirectly, of
securities of the Company  representing  greater than 10% of the combined voting
power of the Company's then  outstanding  securities  (determined by taking into
account as though converted or exercised any securities  convertible into voting
securities or any options  exercisable  for voting  securities,  but only to the
extent such convertible  securities or options are beneficially owned or held by
such person); (iv) any person files soliciting materials intended to result in a
change in the  composition of the Board of Directors of the Company;  or (v) the
Board of Directors of the Company  adopts a resolution  to the effect that,  for
purposes of this Agreement, a Potential Change of Control has occurred.

              3. EMPLOYMENT PERIOD. Subject to Section 6 of this Agreement,  the
Company agrees to continue the Executive in its employ, and the Executive agrees
to remain in the employ of the Company, for the period (the "Employment Period")
commencing on the Change of Control Date and ending on the second anniversary of
the Change of Control Date.

              4. POSITION AND DUTIES.  (a) NO REDUCTION IN POSITION.  During the
Employment Period, the Executive's  position (including  titles),  authority and
responsibilities  shall be at least commensurate with those held,  exercised and
assigned  immediately  prior to the  Change of  Control  Date.  The  Executive's
services  shall be performed at the location  where the  Executive  was employed
immediately preceding the Change of Control Date.

              (b) BUSINESS TIME.  From and after the Change of Control Date, the
Executive  agrees to devote his full attention  during normal  business hours to
the  business  and  affairs  of  the  Company  and  to  perform  faithfully  and
efficiently  the  responsibilities  assigned  to him  hereunder,  to the  extent
necessary to discharge  such  responsibilities,  except for periods of vacation,
sick leave and other leave to which he is entitled.  It is expressly  understood
and agreed that the Executive's continuing to serve on any boards and committees
on which he is  serving  or with which he is  otherwise  associated  immediately
preceding the Change of Control


<PAGE>



Date shall not be deemed to interfere with the  performance  of the  Executive's
services to the Company.

              5.  COMPENSATION.  (a) BASE SALARY.  During the Employment Period,
the  Executive  shall  receive a base salary at a monthly rate at least equal to
the monthly salary paid to the Executive by the Company immediately prior to the
Change of Control  Date.  The base  salary  shall be reviewed at least once each
year after the Change of Control Date,  and may be increased (but not decreased)
at any time and from time to time by action  of the  Board of  Directors  or any
committee  thereof or any  individual  having  authority  to take such action in
accordance with the Company's regular practices. The Executive's base salary, as
it may be increased from time to time,  shall  hereafter be referred to as "Base
Salary".  Neither  the Base Salary nor any  increase  in Base  Salary  after the
Change of Control  Date shall serve to limit or reduce any other  obligation  of
the Company hereunder.

         (b) ANNUAL  BONUS AND  INCENTIVE  COMPENSATION.  During the  Employment
Period,  in  addition  to the Base  Salary,  for each fiscal year of the Company
ending during the Employment  Period, the Executive shall be entitled to receive
(I) an annual  bonus  which is at least  equal to the greater of (1) the highest
annual  bonus,  including,  without  limitation,  any bonus  provided  under the
Company's  Annual  Incentive  Plan,  that had been  payable to the  Executive in
respect of either of the last two fiscal  years ended  immediately  prior to the
Change of  Control  Date or (2) the amount  that would have been  payable to the
Executive as a target bonus including,  without limitation,  under the Company's
Annual  Incentive  Plan,  for the year in which the Change of Control occurs and
(II) long-term incentive  compensation  opportunities on terms and conditions no
less favorable to the Executive than those  applicable to the Executive prior to
the Change of Control  Date.  Any amount  payable  hereunder  as an annual bonus
shall be paid as soon as practicable  following the year for which the amount is
payable,  unless electively  deferred by the Executive  pursuant to any deferral
programs or arrangements that the Company may make available to the Executive.

         (c) BENEFIT PLANS. During the Employment Period, the Executive (and, to
the extent applicable, his dependents) shall be entitled to participate in or be
covered under all pension, retirement, deferred compensation,  savings, medical,
dental,  health,  disability,  group life,  accidental death and travel accident
insurance  plans  at  a  level  that  is   commensurate   with  the  Executive's
participation in such plans immediately prior to the Change of Control Date, or,
if more favorable to the Executive, at the level made available to the Executive
or other similarly situated officers at any time thereafter. The Executive shall
also be entitled to receive such  perquisites as were generally  provided to the
Executive in accordance  with the Company's  policies and practices  immediately
prior to the Change of Control Date.

         (d) EXPENSES.  During the  Employment  Period,  the Executive  shall be
entitled to receive prompt reimbursement for all reasonable expenses incurred by
the Executive in accordance  with the policies and  procedures of the Company as
in effect immediately prior to the Change of Control Date.  Notwithstanding  the
foregoing, the Company may apply the policies and procedures in effect after the
Change of Control Date to the Executive, if such


<PAGE>



policies and procedures are more favorable to the Executive than those in effect
immediately prior to the Change of Control Date.

         (e)  INDEMNIFICATION.  During  and after  the  Employment  Period,  the
Company shall  indemnify the Executive and hold the Executive  harmless from and
against  any  claim,  loss  or  cause  of  action  arising  from  or  out of the
Executive's  performance  as an officer,  director or employee of the Company or
any of its  subsidiaries  or in any  other  capacity,  including  any  fiduciary
capacity,  in which the  Executive  serves at the  request of the Company to the
maximum  extent  permitted by applicable  law and the Company's  Certificate  of
Incorporation and By-Laws (the "Governing Documents"), PROVIDED THAT in no event
shall the  protection  afforded  to the  Executive  hereunder  be less than that
afforded  under the Governing  Documents as in effect  immediately  prior to the
Change of Control Date.

              6.  TERMINATION.   (a)  DEATH,  DISABILITY  OR  RETIREMENT.   This
Agreement shall terminate automatically upon the Executive's death,  termination
due to "Disability" (as defined below) or voluntary  retirement under any of the
Company's  retirement plans as in effect from time to time. For purposes of this
Agreement, Disability shall mean the Executive's inability to perform the duties
of his position,  as determined in accordance  with the policies and  procedures
applicable with respect to the Company's long-term disability plan, as in effect
immediately prior to the Change of Control Date.

              (b)  VOLUNTARY  TERMINATION.   Notwithstanding  anything  in  this
Agreement to the contrary, following a Change of Control the Executive may, upon
not less than 10 days' written notice to the Company,  voluntarily terminate his
employment for any reason  (including early retirement under the terms of any of
the Company's  retirement  plans as in effect from time to time),  PROVIDED THAT
any  termination  by the  Executive  pursuant to Section 6(d) on account of Good
Reason (as  defined  therein)  shall not be treated as a  voluntary  termination
under this Section 6(b).

              (c) CAUSE.  The Company may terminate the  Executive's  employment
for Cause.  For purposes of this  Agreement,  "Cause" means (I) the  Executive's
conviction  or plea  of  NOLO  CONTENDERE  to a  felony;  (II) an act or acts of
extreme  dishonesty or gross  misconduct on the Executive's part which result or
are  intended  to  result  in  material  damage  to the  Company's  business  or
reputation;  or (III)  repeated  material  violations  by the  Executive  of his
obligations under Section 4 of this Agreement, which violations are demonstrably
willful and  deliberate  on the  Executive's  part and which  result in material
damage to the Company's business or reputation.

              (d) GOOD REASON.  Following the occurrence of a Change of Control,
the Executive may terminate his employment for Good Reason. For purposes of this
Agreement,  "Good Reason" means the occurrence of any of the following,  without
the express written  consent of the Executive,  after the occurrence of a Change
of Control:

              (i) (A) the assignment to the Executive of any duties inconsistent
         in  any  material  adverse  respect  with  the  Executive's   position,
         authority or responsibilities as


<PAGE>



         contemplated by Section 4 of this Agreement,  or (B) any other material
         adverse  change  in  such  position,  including  titles,  authority  or
         responsibilities;

              (ii)  any  failure  by  the  Company  to  comply  with  any of the
         provisions of Section 5 of this Agreement,  other than an insubstantial
         or inadvertent  failure  remedied by the Company promptly after receipt
         of notice thereof given by the Executive;

              (iii) the  Company's  requiring  the  Executive to be based at any
         office or  location  more than 20 miles from that  location at which he
         performed  his services  specified  under the  provisions  of Section 4
         immediately  prior  to  the  Change  of  Control,   except  for  travel
         reasonably   required   in   the   performance   of   the   Executive's
         responsibilities; or

              (iv) any  failure  by the  Company to obtain  the  assumption  and
         agreement to perform this Agreement by a successor as  contemplated  by
         Section 11(b).

In no event shall the mere occurrence of a Change of Control, absent any further
impact on the Executive, be deemed to constitute Good Reason.

              (e) NOTICE OF  TERMINATION.  Any  termination  by the  Company for
Cause or by the  Executive  for Good Reason shall be  communicated  by Notice of
Termination  to the other party hereto given in accordance  with Section  12(e).
For purposes of this Agreement, a "Notice of Termination" means a written notice
given,  in the case of a termination  for Cause,  within 10 business days of the
Company's having actual knowledge of the events giving rise to such termination,
and in the  case of a  termination  for  Good  Reason,  within  180  days of the
Executive's   having  actual  knowledge  of  the  events  giving  rise  to  such
termination,  and which (I) indicates the specific termination provision in this
Agreement  relied  upon,  (II) sets  forth in  reasonable  detail  the facts and
circumstances  claimed to  provide a basis for  termination  of the  Executive's
employment  under the provision so indicated,  and (III) if the termination date
is other than the date of receipt of such notice, specifies the termination date
of this Agreement (which date shall be not more than 15 days after the giving of
such  notice).  The  failure  by the  Executive  to set  forth in the  Notice of
Termination  any fact or  circumstance  which  contributes  to a showing of Good
Reason  shall not waive any right of the  Executive  hereunder  or preclude  the
Executive  from  asserting  such fact or  circumstance  in enforcing  his rights
hereunder.

              (f) DATE OF TERMINATION.  For the purpose of this  Agreement,  the
term "Date of  Termination"  means (I) in the case of a termination  for which a
Notice  of  Termination  is  required,  the date of  receipt  of such  Notice of
Termination or, if later,  the date specified  therein,  as the case may be, and
(II) in all other  cases,  the actual date on which the  Executive's  employment
terminates during the Employment Period.

              7.  OBLIGATIONS  OF THE  COMPANY  UPON  TERMINATION.  (a) DEATH OR
DISABILITY.  If the Executive's  employment is terminated  during the Employment
Period by reason of the  Executive's  death or Disability,  this Agreement shall
terminate without further  obligations to the Executive or the Executive's legal
representatives  under  this  Agreement  other than  those  obligations  accrued
hereunder at the Date of Termination, and the Company shall pay to the


<PAGE>



Executive (or his  beneficiary or estate) (I) the  Executive's  full Base Salary
through the Date of Termination (the "Earned  Salary"),  (II) any vested amounts
or benefits  owing to the  Executive  under the Company's  otherwise  applicable
employee  benefit plans and  programs,  including  any  compensation  previously
deferred by the Executive  (together with any accrued earnings  thereon) and not
yet paid by the Company and any accrued vacation pay not yet paid by the Company
(the "Accrued  Obligations"),  and (III) any other  benefits  payable due to the
Executive's death or Disability under the Company's plans,  policies or programs
(the "Additional Benefits").

              Any Earned  Salary  shall be paid in cash in a single  lump sum as
soon as  practicable,  but in no event  more than 10  business  days (or at such
earlier  date  required  by law),  following  the Date of  Termination.  Accrued
Obligations  and Additional  Benefits shall be paid in accordance with the terms
of the applicable plan, program or arrangement.

              (b) CAUSE AND VOLUNTARY  TERMINATION.  If,  during the  Employment
Period, the Executive's  employment shall be terminated for Cause or voluntarily
terminated  by the Executive  (other than on account of Good Reason  following a
Change of Control) in accordance  with Section  6(b),  the Company shall pay the
Executive  (I)  the  Earned  Salary  in  cash in a  single  lump  sum as soon as
practicable,  but  in no  event  more  than  10  days,  following  the  Date  of
Termination,  and (II) the Accrued  Obligations in accordance  with the terms of
the applicable plan, program or arrangement.

              (c)  TERMINATION  BY THE  COMPANY  OTHER  THAN FOR  CAUSE AND GOOD
REASON TERMINATION BY THE EXECUTIVE.

              (i)  LUMP  SUM  PAYMENTS.   If  (X)  the  Company  terminates  the
         Executive's  employment  other  than for Cause  during  the  Employment
         Period or (Y) the Executive  terminates  his employment for Good Reason
         at any time during the Employment  Period then the Company shall pay to
         the Executive the following amounts:

              (A) the Executive's Earned Salary;

              (B) a cash amount (the "Severance  Amount") equal to [three] [two]
                  [one]1 times the sum of

                  (1)      the Executive's annual Base Salary; and

                  (2)      the  greater of (i) the  average of the bonus  amount
                           payable  (including  any  amounts  payable  under the
                           Annual Incentive Plan) to the Executive for the three
                           fiscal years of the Company immediately preceding the
                           Change in  Control  or (Y) the  average  of the bonus
                           amount  payable  (including  any amount payable under
                           the Annual Incentive Plan) to the Executive for
- --------
1 Applies to five Executives, seven Executives, and 18 Executives, respectively.


<PAGE>



                           the three fiscal years of the Company ending 
                           immediately prior to the Date of Termination; and

              (C) the Accrued Obligations.

         The  Earned  Salary  and  Severance  Amount  shall be paid in cash in a
         single  lump sum as soon as  practicable,  but in no event more than 10
         business days (or at such earlier date required by law),  following the
         Date of Termination.  Accrued  Obligations  shall be paid in accordance
         with the terms of the applicable plan, program or arrangement.

              (ii) SUPPLEMENTAL  RETIREMENT  BENEFIT. In the event the Executive
         is  entitled  to receive  the  Severance  Amount  described  in Section
         7(c)(i), the Executive (and, to the extent applicable,  his dependents)
         shall be entitled to receive a supplemental  retirement benefit payable
         pursuant to a deferred  annuity  contract  issued by a solvent  insurer
         mutually  acceptable  to the Company and the Executive and purchased by
         the Company and  delivered  to the  Executive  within 60 days after the
         Date of  Termination.  Such annuity  contract shall provide for monthly
         payments on and after the  Executive's  65th birthday and 100% survivor
         benefits to the Executive's  spouse for such  individual's  lifetime in
         the  event of the  Executive's  death  prior to or  after  age 65.  The
         monthly  benefits to be provided by the annuity  shall be determined as
         follows:

              (A) three years shall be added to Executive's  credited service as
                  determined at Date of Termination under the terms of Company's
                  qualified   defined  benefit  pension  plan  and  supplemental
                  pension plan (collectively,  the "Pension Plans") as in effect
                  immediately  prior to the  Change in Control  (subject  to any
                  applicable maximum on credited service) PROVIDED THAT, for the
                  purposes of this Section  7(c)(ii),  Executive shall be deemed
                  to be a Participant  in such  supplemental  pension plan as of
                  the Date of Termination;

              (B) using such adjusted  credited  service,  a new monthly benefit
                  for life  commencing  at age 65 shall be  determined as of the
                  Date of Termination under the terms of the Pension Plans;

              (C) from such monthly  benefit as calculated in (B) above shall be
                  subtracted  the monthly vested  deferred  benefit of Executive
                  due to be  paid on and  after  attainment  of age 65,  if any,
                  pursuant to the terms of all defined  benefit  pension  plans,
                  active or frozen,  in which  Executive is a participant at his
                  Date  of  Termination  if  such  plans  are  sponsored  by the
                  Company, its successors or affiliates thereof; and

              (D) in  accordance  with  the  terms  of the  Pension  Plans,  the
                  difference described in (C) next above shall be converted from
                  a  monthly  lifetime  benefit  after  age 65 to the  actuarial
                  equivalent monthly benefit on and


<PAGE>



                  after   attainment   of  age  65  which   provides   the  100%
                  survivorship  feature  first above  described  in this Section
                  7(c)(ii).

         For purposes of making the foregoing determinations,  at the request of
         Executive in the Notice of Termination given by Executive or in writing
         within 3 days of Executive's  receipt of Notice of Termination,  but in
         either event at Company expense,  the independent  pension  consultants
         most recently used by Company in connection with its qualified  pension
         plan prior to the Change in Control  shall be engaged and shall certify
         the  benefits  due  Executive  under this  Section  7(c)(ii) in writing
         within  30 days  after  the Date of  Termination.  If the  amount to be
         offset under  subparagraph (C) above shall not be determined by the end
         of a period of 30 days after the Date of  Termination,  no such  offset
         shall be permitted.

              (iii)  CONTINUATION  OF  BENEFITS.  In the event the  Executive is
         entitled to receive the Severance  Amount described in Section 7(c)(i),
         the Executive (and, to the extent applicable,  his dependents) shall be
         entitled,  after the Date of  Termination  until the earlier of (1) the
         second  anniversary of the Date of Termination  (the "End Date") or (2)
         the date the Executive becomes eligible for comparable benefits under a
         similar plan, policy or program of a subsequent  employer,  to continue
         participation  in all of the Company's  employee  welfare benefit plans
         including,   without  limitation,  the  Company's  hospital,   medical,
         accident, disability, and life insurance plans (the "Benefit Plans") as
         were  generally  provided  to the  Executive  in  accordance  with  the
         Company's  policies and  practices  immediately  prior to the Change of
         Control Date. To the extent any such benefits  cannot be provided under
         the terms of the applicable plan, policy or program,  the Company shall
         provide a comparable  benefit  under another plan or from the Company's
         general assets. The Executive's participation in the Benefit Plans will
         be on the same terms and  conditions  that would have  applied  had the
         Executive continued to be employed by the Company through the End Date.

              (d)  DISCHARGE OF THE COMPANY'S  OBLIGATIONS.  Except as expressly
provided in the last sentence of this Section 7(d),  the amounts  payable to the
Executive pursuant to this Section 7 (whether or not reduced pursuant to Section
7(e))  following  termination  of his  employment  shall be in full and complete
satisfaction of the Executive's rights under this Agreement and any other claims
he  may  have  in  respect  of  his  employment  by  the  Company  or any of its
subsidiaries.  Such amounts shall constitute  liquidated damages with respect to
any and all such rights and claims  and,  upon the  Executive's  receipt of such
amounts, the Company shall be released and discharged from any and all liability
to the  Executive in connection  with this  Agreement or otherwise in connection
with the Executive's  employment with the Company and its subsidiaries.  Nothing
in this  Section  7(d)  shall be  construed  to  release  the  Company  from its
commitment to indemnify  the Executive and hold the Executive  harmless from and
against  any  claim,  loss  or  cause  of  action  arising  from  or  out of the
Executive's  performance  as an officer,  director or employee of the Company or
any of its  subsidiaries  or in any  other  capacity,  including  any  fiduciary
capacity,  in which the  Executive  served at the  request of the Company to the
maximum extent permitted by applicable law and the Governing Documents.



<PAGE>



              (e)  CERTAIN FURTHER PAYMENTS BY THE COMPANY.

              (i) In the event that any amount or benefit paid or distributed to
         the  Executive  pursuant to this  Agreement,  taken  together  with any
         amounts or benefits  otherwise  paid or distributed to the Executive by
         the Company or any affiliated  company including,  without  limitation,
         any distribution or payment made pursuant to the terms of the Company's
         compensation   plans  or  arrangements   (collectively,   the  "Covered
         Payments"), are or become subject to the tax (the "Excise Tax") imposed
         under  Section  4999 of the Internal  Revenue Code of 1986,  as amended
         (the  "Code"),  or any similar tax that may  hereafter be imposed,  the
         Company  shall pay to the  Executive  at the time  specified in Section
         7(e)(v) below an additional  amount (the "Tax  Reimbursement  Payment")
         such that the net amount retained by the Executive with respect to such
         Covered  Payments,  after  deduction  of any Excise Tax on the  Covered
         Payments and any Federal,  state and local income or employment tax and
         Excise  Tax on the  Tax  Reimbursement  Payment  provided  for by  this
         Section  7(e),  but before  deduction  for any Federal,  state or local
         income or employment tax withholding on such Covered Payments, shall be
         equal to the amount of the Covered Payments.

              (ii)  For  purposes  of  determining  whether  any of the  Covered
         Payments  will be  subject  to the  Excise  Tax and the  amount of such
         Excise Tax,

              (A) such Covered Payments will be treated as "parachute  payments"
                  within  the  meaning  of  Section  280G of the  Code,  and all
                  "parachute  payments"  in  excess  of the  "base  amount"  (as
                  defined under Section 280G(b)(3) of the Code) shall be treated
                  as subject to the Excise Tax, unless, and except to the extent
                  that, in the good faith judgment of the Company's  independent
                  certified public accountants  appointed prior to the Change of
                  Control Date or tax counsel  selected by such Accountants (the
                  "Accountants"), the Company has a reasonable basis to conclude
                  that such Covered Payments (in whole or in part) either do not
                  constitute   "parachute   payments"  or  represent  reasonable
                  compensation for personal  services  actually rendered (within
                  the meaning of Section 280G(b)(4)(B) of the Code) in excess of
                  the "base amount," or such "parachute  payments" are otherwise
                  not subject to such Excise Tax, and

              (B) the value of any non-cash  benefits or any deferred payment or
                  benefit shall be determined by the  Accountants  in accordance
                  with the principles of Section 280G of the Code.

              (iii)  For  purposes  of   determining   the  amount  of  the  Tax
         Reimbursement Payment, the Executive shall be deemed to pay:

              (A) Federal income taxes at the highest  applicable  marginal rate
                  of Federal income  taxation for the calendar year in which the
                  Tax Reimbursement Payment is to be made, and


<PAGE>



              (B) any  applicable  state and local  income  taxes at the highest
                  applicable  marginal rate of taxation for the calendar year in
                  which the Tax Reimbursement  Payment is to be made, net of the
                  maximum  reduction  in Federal  income  taxes  which  could be
                  obtained  from the  deduction  of such state or local taxes if
                  paid in such year.

              (iv) In the event that the Excise Tax is  subsequently  determined
         by the Accountants or pursuant to any proceeding or  negotiations  with
         the  Internal  Revenue  Service to be less than the  amount  taken into
         account  hereunder in calculating the Tax  Reimbursement  Payment made,
         the Executive  shall repay to the Company,  at the time that the amount
         of such reduction in the Excise Tax is finally determined,  the portion
         of such prior Tax  Reimbursement  Payment that would not have been paid
         if such Excise Tax had been applied in initially  calculating  such Tax
         Reimbursement Payment, plus interest on the amount of such repayment at
         the rate provided in Section 1274(b)(2)(B) of the Code. Notwithstanding
         the  foregoing,  in the  event  any  portion  of the Tax  Reimbursement
         Payment to be refunded  to the  Company  has been paid to any  Federal,
         state or local tax authority,  repayment  thereof shall not be required
         until  actual  refund or credit  of such  portion  has been made to the
         Executive,  and  interest  payable  to the  Company  shall  not  exceed
         interest  received or credited to the  Executive by such tax  authority
         for the period it held such  portion.  The  Executive  and the  Company
         shall  mutually  agree upon the course of action to be pursued (and the
         method of  allocating  the expenses  thereof) if the  Executive's  good
         faith claim for refund or credit is denied.

              In the  event  that  the  Excise  Tax is later  determined  by the
         Accountants  or pursuant to any  proceeding  or  negotiations  with the
         Internal  Revenue  Service  to exceed the  amount  taken  into  account
         hereunder at the time the Tax Reimbursement Payment is made (including,
         but not limited to, by reason of any payment the existence or amount of
         which  cannot  be  determined  at the  time  of the  Tax  Reimbursement
         Payment),  the  Company  shall  make an  additional  Tax  Reimbursement
         Payment in respect of such excess (plus any interest or penalty payable
         with respect to such excess) at the time that the amount of such excess
         is finally determined.

              (v) The Tax  Reimbursement  Payment (or portion thereof)  provided
         for in Section  7(e)(i)  above shall be paid to the Executive not later
         than 10 business days  following  the payment of the Covered  Payments;
         provided, however, that if the amount of such Tax Reimbursement Payment
         (or portion thereof) cannot be finally determined on or before the date
         on which payment is due, the Company shall pay to the Executive by such
         date an amount  estimated  in good faith by the  Accountants  to be the
         minimum  amount  of such Tax  Reimbursement  Payment  and shall pay the
         remainder of such Tax Reimbursement  Payment (together with interest at
         the rate provided in Section  1274(b)(2)(B) of the Code) as soon as the
         amount  thereof  can be  determined,  but in no  event  later  than  45
         calendar  days after  payment of the related  Covered  Payment.  In the
         event  that the  amount  of the  estimated  Tax  Reimbursement  Payment
         exceeds  the  amount  subsequently  determined  to have been due,  such
         excess shall constitute a loan by the Company to the Executive, payable
         on the fifth business day after written demand by


<PAGE>



         the Company for payment (together with interest at the rate provided in
         Section 1274(b)(2)(B) of the Code).

              8. NON-EXCLUSIVITY OF RIGHTS. Except as expressly provided herein,
nothing in this Agreement shall prevent or limit the  Executive's  continuing or
future participation in any benefit,  bonus,  incentive or other plan or program
provided by the  Company or any of its  affiliated  companies  and for which the
Executive may qualify,  nor shall anything  herein limit or otherwise  prejudice
such  rights as the  Executive  may have  under any  other  agreements  with the
Company or any of its affiliated companies. Amounts which are vested benefits or
which the  Executive is otherwise  entitled to receive under any plan or program
of the Company or any of its  affiliated  companies at or subsequent to the Date
of Termination shall be payable in accordance with such plan or program.

              9. FULL SETTLEMENT.  The Company's obligation to make the payments
provided  for in  this  Agreement  and  otherwise  to  perform  its  obligations
hereunder  shall  not be  affected  by  any  circumstances,  including,  without
limitation, any set-off, counterclaim,  recoupment, defense or other right which
the Company may have against the  Executive  or others  whether by reason of the
subsequent employment of the Executive or otherwise.

              10. LEGAL FEES AND EXPENSES. If the Executive asserts any claim in
any contest  (whether  initiated  by the  Executive or by the Company) as to the
validity,  enforceability  or interpretation of any provision of this Agreement,
the Company shall pay the Executive's  legal expenses (or cause such expenses to
be paid) including,  without  limitation,  his reasonable  attorney's fees, on a
quarterly basis, upon presentation of proof of such expenses,  PROVIDED THAT the
Executive  shall  reimburse the Company for such amounts,  plus simple  interest
thereon at the 90-day United States Treasury Bill rate as in effect from time to
time,  compounded  annually,  if the Executive shall not prevail, in whole or in
part,  as  to  any  material  issue  as  to  the  validity,   enforceability  or
interpretation of any provision of this Agreement.

              11.  SUCCESSORS.

              (a) This Agreement is personal to the Executive  and,  without the
prior written  consent of the Company,  shall not be assignable by the Executive
otherwise than by will or the laws of descent and  distribution.  This Agreement
shall  inure to the  benefit  of and be  enforceable  by the  Executive's  legal
representatives.

              (b) This  Agreement  shall  inure to the benefit of and be binding
upon the Company and its successors.  The Company shall require any successor to
all or substantially  all of the business and/or assets of the Company,  whether
direct or indirect, by purchase, merger, consolidation, acquisition of stock, or
otherwise,  by an agreement in form and substance satisfactory to the Executive,
expressly to assume and agree to perform  this  Agreement in the same manner and
to the same  extent as the  Company  would be  required  to  perform  if no such
succession had taken place.




<PAGE>



              12.  MISCELLANEOUS.

              (a)  APPLICABLE  LAW.  This  Agreement  shall be  governed  by and
construed  and  conferred in  accordance  with the laws of the State of Delaware
applied without reference to principles of conflict of laws.

              (b)  ARBITRATION.  Any dispute or controversy  arising under or in
connection  with this Agreement  shall be resolved by binding  arbitration.  The
arbitration  shall be held at a site selected by the  arbitrators  and except to
the extent  inconsistent  with this Agreement,  shall be conducted in accordance
with the  Expedited  Employment  Arbitration  Rules of the American  Arbitration
Association  then in effect at the time of the  arbitration,  and  otherwise  in
accordance with  principles  which would be applied by a court of law or equity.
The arbitrator shall be acceptable to both the Company and the Executive. If the
parties cannot agree on an acceptable arbitrator,  the dispute shall be heard by
a panel of three arbitrators, one appointed by each of the parties and the third
appointed by the other two arbitrators.

              (c)  AMENDMENTS.  This Agreement may be amended or modified by the
Board of  Directors  at any time  prior to a Change  in  Control  PROVIDED  THAT
subsequent to the  occurrence of a Potential  Change in Control,  this Agreement
may not be amended or modified otherwise than by a written agreement executed by
the parties hereto or their  respective  successors  and legal  representatives.
Notwithstanding  the  foregoing  sentence,  in the event that  subsequent to the
occurrence of a Potential  Change in Control (i) the Board of Directors  makes a
good faith  determination  that the events giving rise to a Potential  Change in
Control  will not  result in the  occurrence  of a Change in  Control or (ii) an
actual  Change in Control has not occurred  after the first  anniversary  of the
occurrence of a Potential  Change in Control (or any Potential Change in Control
events occurring after the initial  Potential Change in Control),  the foregoing
limitation on the amendment or  modification  of this  Agreement  shall cease to
apply unless and until it thereafter  again  becomes  effective by reason of the
occurrence  of another  Potential  Change in  Control  or any  actual  Change in
Control.

              (d)  ENTIRE  AGREEMENT.  Upon the  Change of  Control  Date,  this
Agreement shall constitute the entire agreement  between the parties hereto with
respect  to  the   matters   referred   to  herein.   There  are  no   promises,
representations,  inducements or statements between the parties other than those
that  are  expressly  contained  herein.  In the  event  any  provision  of this
Agreement is invalid or  unenforceable,  the validity and  enforceability of the
remaining  provisions hereof shall not be affected.  The Executive  acknowledges
that he is entering  into this  Agreement  of his own free will and accord,  and
with no duress,  that he has read this  Agreement and that he understands it and
its legal consequences.




<PAGE>



              (e) NOTICES. All notices and other communications  hereunder shall
be in  writing  and shall be given by  hand-delivery  to the  other  party or by
registered  or  certified  mail,  return  receipt  requested,  postage  prepaid,
addressed as follows:

         If to the Executive:              at the home address of the Executive 
                                           noted on the records of the Company

         If to the Company:                Protective Life Corporation
                                           2801 Highway 280 South
                                           Birmingham, Alabama 35223
                                           Attn.:  Deborah J. Long
                                                    Senior Vice President
                                                    General Counsel

or to such other  address as either  party shall have  furnished to the other in
writing in accordance  herewith.  Notice and  communications  shall be effective
when actually received by the addressee.



<PAGE>


                  IN WITNESS  WHEREOF,  the  Executive has hereunto set his hand
and the  Company  has caused  this  Agreement  to be executed in its name on its
behalf,  and its  corporate  seal to be  hereunto  affixed  and  attested by its
Secretary, all as of the day and year first above written.


                                        PROTECTIVE LIFE CORPORATION


                                        By: ______________________________
                                        Name:    Drayton Nabers, Jr.
                                        Title:   Chairman of the Board and
                                                 Chief Executive Officer

ATTEST:

By:_________________________
Name:  _____________________
Title: _____________________



                                            EXECUTIVE


                                            Signature:_______________________
                                            Name:       _____________________
                                            Title:  _________________________




                                                                 Exhibit 15






Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C.  20549



Re:     Protective Life Corporation



We are aware that our report dated  October 23,  1997,  on our review of interim
consolidated   financial   information  of  Protective   Life   Corporation  and
subsidiaries  for the period  ended  September  30,  1997,  and  included in the
Company's  quarterly  report  on  Form  10-Q  for the  quarter  then  ended,  is
incorporated by reference in the Company's  registration  statements on Form S-8
and Form S-3.  Pursuant to Rule 436(c) under the  Securities  Act of 1933,  this
report should not be considered a part of the registration  statements  prepared
or certified by us within the meaning of Sections 7 and 11 of that Act.





COOPERS & LYBRAND L.L.P.


Birmingham, Alabama
November 11, 1997
                                       

<TABLE> <S> <C>

<ARTICLE>                                           7
<LEGEND>
This schedule contains summary financial information extracted from the
consolidated financial statements of Protective Life Corporation and is 
qualified in its entirety by reference to such financial statements.
</LEGEND>                                             
<MULTIPLIER>                                    1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              DEC-31-1997
<PERIOD-START>                                 JAN-01-1997
<PERIOD-END>                                   SEP-30-1997
<DEBT-HELD-FOR-SALE>                           6,157,588
<DEBT-CARRYING-VALUE>                          0
<DEBT-MARKET-VALUE>                            0
<EQUITIES>                                     18,620
<MORTGAGE>                                     1,261,809
<REAL-ESTATE>                                  14,770
<TOTAL-INVEST>                                 7,916,070
<CASH>                                         310
<RECOVER-REINSURE>                             473,521
<DEFERRED-ACQUISITION>                         630,330
<TOTAL-ASSETS>                                 10,155,520
<POLICY-LOSSES>                                3,331,012
<UNEARNED-PREMIUMS>                            253,192
<POLICY-OTHER>                                 0
<POLICY-HOLDER-FUNDS>                          170,051
<NOTES-PAYABLE>                                138,600
                          0
                                    0
<COMMON>                                       16,668
<OTHER-SE>                                     694,260
<TOTAL-LIABILITY-AND-EQUITY>                   10,155,520
                                     363,817
<INVESTMENT-INCOME>                            426,001
<INVESTMENT-GAINS>                             786
<OTHER-INCOME>                                 21,890
<BENEFITS>                                     496,712
<UNDERWRITING-AMORTIZATION>                    67,561
<UNDERWRITING-OTHER>                           116,618
<INCOME-PRETAX>                                131,603
<INCOME-TAX>                                   44,745
<INCOME-CONTINUING>                            82,747<F1>
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   82,747
<EPS-PRIMARY>                                  2.65
<EPS-DILUTED>                                  2.65
<RESERVE-OPEN>                                 0
<PROVISION-CURRENT>                            0
<PROVISION-PRIOR>                              0
<PAYMENTS-CURRENT>                             0
<PAYMENTS-PRIOR>                               0
<RESERVE-CLOSE>                                0
<CUMULATIVE-DEFICIENCY>                        0
<FN>
<F1>Net of minority interest in income of consolidated subsidiaries of $4,111.
</FN>
        

</TABLE>




                                   Exhibit 99
                                       to
                                    Form 10-Q
                                       of
                           Protective Life Corporation
                               for the nine months
                            Ended September 30, 1997


                   Safe Harbor for Forward-Looking Statements


         The  Private  Securities  Litigation  Reform  Act of 1995  (the  "Act")
encourages  companies to make  "forward-looking  statements"  by creating a safe
harbor to protect the companies from securities law liability in connection with
forward-looking statements.  Forward-looking statements can be identified by use
of  words  such  as  "expect,"  "estimate,"  "project,  "  budget,"  "forecast,"
"anticipate," "plan," and similar expressions.  Protective Life Corporation (the
"Company")  intends  to  qualify  both  its  written  and  oral  forward-looking
statements for protection under the Act.

         To qualify oral  forward-looking  statements for  protection  under the
Act, a readily available  written document must identify  important factors that
could   cause   actual   results  to  differ   materially   from  those  in  the
forward-looking  statements.  The Company provides the following  information to
qualify forward-looking statements for the safe harbor protection of the Act.

         The  operating  results of companies  in the  insurance  industry  have
historically  been  subject  to  significant  fluctuations  due to  competition,
economic  conditions,  interest rates,  investment  performance,  maintenance of
insurance  ratings,  and other factors.  Certain known trends and  uncertainties
which may affect future results of the Company are discussed more fully below.

         MATURE  INDUSTRY;  COMPETITION.  Life and health  insurance is a mature
industry.  In recent years, the industry has experienced  virtually no growth in
life insurance  sales,  though the aging population has increased the demand for
retirement  savings products.  Life and health insurance is a highly competitive
industry and the Company's  Divisions encounter  significant  competition in all
their respective lines of business from other insurance companies, many of which
have greater financial  resources than the Company,  as well as competition from
other providers of financial services.

         Management  believes that the Company's ability to compete is dependent
upon,  among  other  things,  its  ability  to attract  and retain  distribution
channels to market its insurance and investment products, its ability to develop
competitive and profitable products, its ability to maintain low unit costs, and
its  maintenance of strong  claims-paying  and financial  strength  ratings from
rating agencies.

         The Company  competes  against other insurance  companies and financial
institutions in the origination of commercial mortgage loans.


<PAGE>



         RATINGS. Ratings are an important factor in the competitive position of
life insurance companies. Rating organizations periodically review the financial
performance  and  condition  of  insurers,  including  the  Company's  insurance
subsidiaries.  A  downgrade  in the  ratings  of the  Company's  life  insurance
subsidiaries  could  adversely  affect its ability to sell its  products and its
ability to compete for attractive acquisition opportunities.

         Rating organizations  assign ratings based upon several factors.  While
most of the considered factors relate to the rated company,  some of the factors
relate to  general  economic  conditions  and  circumstances  outside  the rated
company's control.

         Rating  downgrades  have exceeded  upgrades for the past several years,
and public  pronouncements  by the rating  agencies  indicate that this trend is
expected to continue for the near future.

     POLICY CLAIMS  FLUCTUATIONS.  The Company's results may fluctuate from year
to year on account of fluctuations in policy claims received by the Company.

         LIQUIDITY AND INVESTMENT PORTFOLIO. Many of the products offered by the
Company's life insurance subsidiaries allow policyholders and contractholders to
withdraw their funds under defined  circumstances.  The Company's life insurance
subsidiaries  design  products  and  configure  investment  portfolios  so as to
provide and  maintain  sufficient  liquidity to support  anticipated  withdrawal
demands  and  contract  benefits  and  maturities.   Asset/liability  management
programs  and  procedures  are used to  monitor  the  relative  duration  of the
Company's   assets  and   liabilities.   While  the  Company's   life  insurance
subsidiaries own a significant amount of liquid assets, many of their assets are
relatively illiquid.  Significant unanticipated withdrawal or surrender activity
could,   under  some   circumstances,   compel  the  Company's   life  insurance
subsidiaries  to dispose of illiquid  assets on unfavorable  terms,  which could
have a material adverse effect on the Company.

         INTEREST  RATE  FLUCTUATIONS.  Significant  changes in  interest  rates
expose life insurance  companies to the risk of not earning  anticipated spreads
between the interest rate earned on  investments  and the interest rate credited
to its life  insurance  and  investment  products.  Both  rising  and  declining
interest rates can negatively  affect the Company's spread income.  For example,
certain of the Company's  insurance and investment  products guarantee a minimum
credited interest rate. While the Company develops and maintains asset/liability
management  programs and procedures designed to preserve spread income in rising
or  falling  interest  rate  environments,   no  assurance  can  be  given  that
significant changes in interest rates will not materially affect such spreads.

         Lower  interest  rates may result in lower sales of the Company's  life
insurance and investment products.

         INVESTMENT RISKS. The Company's invested assets are subject to inherent
risks of  defaults  and  changes in market  values.  The value of the  Company's
commercial  mortgage portfolio depends in part on the financial condition of the
tenants  occupying the  properties on which the Company has made loans.  Factors
that may affect the overall default rate on, and


<PAGE>



market value of, the  Company's  invested  assets  include the level of interest
rates, performance of the financial markets, and general economic conditions, as
well  as  particular   circumstances  affecting  the  businesses  of  individual
borrowers and tenants.

         CONTINUING  SUCCESS OF ACQUISITION  STRATEGY.  The Company has actively
pursued a strategy of acquiring blocks of insurance  policies.  This acquisition
strategy has increased the Company's earnings in part by allowing the Company to
position  itself to  realize  certain  operating  efficiencies  associated  with
economies  of  scale.  There  can  be  no  assurance,   however,  that  suitable
acquisitions,  presenting  opportunities  for  continued  growth  and  operating
efficiencies,  will continue to be available to the Company, or that the Company
will realize the anticipated financial results from its acquisitions.

         REGULATION  AND TAXATION.  The  Company's  insurance  subsidiaries  are
subject to  government  regulation  in each of the states in which they  conduct
business.   Such   regulation   is  vested  in  state   agencies   having  broad
administrative  power  dealing  with  all  aspects  of  the  insurance  business
including premium rates,  benefits,  marketing  practices,  advertising,  policy
forms,  underwriting standards, and capital adequacy, and is concerned primarily
with the  protection  of  policyholders  rather than  stockholders.  The Company
cannot predict the form of any future regulatory initiatives.

         Under the Internal Revenue Code of 1986, as amended (the Code),  income
tax payable by  policyholders  on  investment  earnings  is deferred  during the
accumulation  period of  certain  life  insurance  and  annuity  products.  This
favorable tax treatment may give certain of the Company's products a competitive
advantage  over other  non-insurance  products.  To the extent  that the Code is
revised  to  reduce  the  tax-deferred  status  of life  insurance  and  annuity
products, or to increase the tax-deferred status of competing products, all life
insurance companies,  including the Company's  subsidiaries,  would be adversely
affected.

         The Company  cannot  predict what future  initiatives  the President or
Congress may propose which may affect the life and health insurance industry and
the Company.

         LITIGATION.  A number of civil jury verdicts have been returned against
life and health insurers in the jurisdictions in which the Company does business
involving the insurers' sales practices,  alleged agent  misconduct,  failure to
properly supervise agents,  and other matters.  Increasingly these lawsuits have
resulted in the award of  substantial  judgments  against  the insurer  that are
disproportionate  to the actual damages,  including material amounts of punitive
damages. In some states (including Alabama),  juries have substantial discretion
in awarding  punitive  damages which  creates the  potential  for  unpredictable
material  adverse  judgments in any given punitive damages suit. The Company and
its subsidiaries, like other life and health insurers, in the ordinary course of
business,  are involved in such  litigation.  The outcome of any such litigation
cannot be predicted  with  certainty.  In addition,  in some lawsuits  involving
insurers' sales practices,  insurers have made material  settlement  payments to
end litigation.

     RELIANCE  UPON THE  PERFORMANCE  OF OTHERS.  The Company  has entered  into
various ventures involving other parties.  Examples include, but are not limited
to: many of the  Company's  products are sold through  independent  distribution
channels; the Investment Products

<PAGE>



Division's   variable   annuity  deposits  are  invested  in  funds  managed  by
unaffiliated  investment  managers;  a  portion  of the  sales in the  Financial
Institutions,  Dental and Consumer Benefits, and Individual Life Divisions comes
from arrangements with unrelated  marketing  organizations;  and the Company has
entered the Hong Kong insurance  market in a joint venture with the Lippo Group.
Therefore the Company's results may be affected by the performance of others.

         REINSURANCE.  As is customary in the insurance industry,  the Company's
insurance subsidiaries cede insurance to other insurance companies. However, the
ceding  insurance  company remains liable with respect to ceded insurance should
any reinsurer  fail to meet the  obligations  assumed by it.  Additionally,  the
Company  assumes  policies of other  insurers.  Any  regulatory or other adverse
development  affecting the ceding  insurer could also have an adverse  effect on
the Company.

         Forward-looking statements express expectations of future events and/or
results.  All  forward-looking  statements are inherently  uncertain as they are
based on various expectations and assumptions  concerning future events and they
are subject to numerous  known and unknown risks and  uncertainties  which could
cause actual events or results to differ materially from those projected. Due to
these inherent uncertainties, investors are urged not to place undue reliance on
forward-looking statements. In addition, the Company undertakes no obligation to
update or revise forward-looking statements to reflect changed assumptions,  the
occurrence of unanticipated events, or changes to projections over time.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission